Market Overview:
The global diclofenac active pharmaceutical ingredients market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and growing demand for generic drugs. In terms of purity, the market is segmented into 99%-99.5%, above 99.5%, and below 99% purity segments.
Product Definition:
Diclofenac is a medication used to treat pain, inflammation, and fever. It is a nonsteroidal anti-inflammatory drug (NSAID).
Purity (99%-99.5%):
Purity (99%-99.5%) is a special category of Pharmaceutical Purity that means 99.5% to 100% content of the substance being purified, in other words it's purest form available in the market and can be used for any pharmaceutical purpose without further purification or fractionation.
Purities greater than 99% are rare.
Purity (above 99.5%):
Purity (above 99.5%) is a term used in the pharmaceutical industry for categorizing an active pharmaceutical ingredient (API) that consists of highly specific and consistent components, which are suitable for producing drugs with high therapeutic efficacy. Purity refers to the quality of being free from any foreign particle or substance; it does not refer to contamination or impurities.
Application Insights:
Reating pain accounted for the largest share of over 50.0% in 2017 in the global diclofenac active pharmaceutical ingredients market owing to its extensive use as an analgesic and anti-inflammatory agent. It is used for treating acute as well as chronic pains, such as arthritis, headache, toothache, and gastrointestinal disorders. Furthermore, it also has a high usage rate for fever management due to its anti-inflammatory property.
Diclofenac is available OTC under various brand names such as Voltaren (Voltaren Dental), Anaprox (Anaplacid), Flexeril (Stablon) and many more across all major regions of the world including Europe, North America and Asia Pacific. The aforementioned factors are anticipated to boost product demand during the forecast period especially in Europe where diclofenac products are available without prescription under specified medical conditions only thus driving growth during this study period.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is anticipated to maintain its position during the forecast period. The region accounts for a major share of global production owing to availability of raw materials, cheap labor, and proximity to end-use markets. China is one of the top producers as well as consumers of diclofenac in this region due to presence of key manufacturers such as Sinofilchem (Jiangsu) Pharmaceutical Co., Ltd., Wuhan Institute For Medical Sciences Corp., Zhejiang Luyuan Bio-Tech Co., Ltd. And many more small scale manufacturers who bring down product prices & availability resulting into high demand & consumption by local population.
In addition, rising incidence/occurrence cases diabetic foot around Asia Pacific has led pharmaceutical companies including Cipla Inc.; Dr Reddy's Laboratories; Sun Pharmaceutical Industries Limited; GSK plc.
Growth Factors:
- Increasing prevalence of chronic diseases: The global Diclofenac Active Pharmaceutical Ingredients market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and arthritis.
- Rising geriatric population: The global geriatric population is expected to increase significantly in the next few years, which will lead to an increase in demand for Diclofenac Active Pharmaceutical Ingredients products for treatment of various chronic diseases.
- Technological advancements: The pharmaceutical industry is witnessing significant advancements in technology that are helping manufacturers develop novel and improved formulations of Diclofenac Active Pharmaceutical Ingredients products. This is likely to boost the growth of the market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diclofenac Active Pharmaceutical Ingredients Market Research Report
By Type
Purity (99%-99.5%), Purity (above 99.5%), Purity (below 99 %)
By Application
Reating Pain, Fever, Inflammation, Others
By Companies
Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Jingye Group, Hunan Zhongnan Pharmaceutical, Elam Pharma Pvt. Ltd. (EPPL), Watanabe Chemical Co., Ltd, Virchow Laboratories Limited
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Diclofenac Active Pharmaceutical Ingredients Market Report Segments:
The global Diclofenac Active Pharmaceutical Ingredients market is segmented on the basis of:
Types
Purity (99%-99.5%), Purity (above 99.5%), Purity (below 99 %)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Reating Pain, Fever, Inflammation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Granules India Limited
- Huagang Pharm
- Hebei Jiheng Pharmaceutical
- Zhejiang Kangle Pharmaceutical
- Jingye Group
- Hunan Zhongnan Pharmaceutical
- Elam Pharma Pvt. Ltd. (EPPL)
- Watanabe Chemical Co., Ltd
- Virchow Laboratories Limited
Highlights of The Diclofenac Active Pharmaceutical Ingredients Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity (99%-99.5%)
- Purity (above 99.5%)
- Purity (below 99 %)
- By Application:
- Reating Pain
- Fever
- Inflammation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diclofenac Active Pharmaceutical Ingredients Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diclofenac is an anti-inflammatory drug that is used to relieve pain and inflammation.
Some of the major players in the diclofenac active pharmaceutical ingredients market are Granules India Limited, Huagang Pharm, Hebei Jiheng Pharmaceutical, Zhejiang Kangle Pharmaceutical, Jingye Group, Hunan Zhongnan Pharmaceutical, Elam Pharma Pvt. Ltd. (EPPL), Watanabe Chemical Co., Ltd, Virchow Laboratories Limited.
The diclofenac active pharmaceutical ingredients market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diclofenac Active Pharmaceutical Ingredients Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Diclofenac Active Pharmaceutical Ingredients Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Diclofenac Active Pharmaceutical Ingredients Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Diclofenac Active Pharmaceutical Ingredients Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Diclofenac Active Pharmaceutical Ingredients Market Size & Forecast, 2018-2028 4.5.1 Diclofenac Active Pharmaceutical Ingredients Market Size and Y-o-Y Growth 4.5.2 Diclofenac Active Pharmaceutical Ingredients Market Absolute $ Opportunity
Chapter 5 Global Diclofenac Active Pharmaceutical Ingredients Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
5.2.1 Purity (99%-99.5%)
5.2.2 Purity (above 99.5%)
5.2.3 Purity (below 99 %)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diclofenac Active Pharmaceutical Ingredients Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
6.2.1 Reating Pain
6.2.2 Fever
6.2.3 Inflammation
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diclofenac Active Pharmaceutical Ingredients Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diclofenac Active Pharmaceutical Ingredients Analysis and Forecast
9.1 Introduction
9.2 North America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
9.6.1 Purity (99%-99.5%)
9.6.2 Purity (above 99.5%)
9.6.3 Purity (below 99 %)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
9.10.1 Reating Pain
9.10.2 Fever
9.10.3 Inflammation
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diclofenac Active Pharmaceutical Ingredients Analysis and Forecast
10.1 Introduction
10.2 Europe Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
10.6.1 Purity (99%-99.5%)
10.6.2 Purity (above 99.5%)
10.6.3 Purity (below 99 %)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
10.10.1 Reating Pain
10.10.2 Fever
10.10.3 Inflammation
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diclofenac Active Pharmaceutical Ingredients Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
11.6.1 Purity (99%-99.5%)
11.6.2 Purity (above 99.5%)
11.6.3 Purity (below 99 %)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
11.10.1 Reating Pain
11.10.2 Fever
11.10.3 Inflammation
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diclofenac Active Pharmaceutical Ingredients Analysis and Forecast
12.1 Introduction
12.2 Latin America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
12.6.1 Purity (99%-99.5%)
12.6.2 Purity (above 99.5%)
12.6.3 Purity (below 99 %)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
12.10.1 Reating Pain
12.10.2 Fever
12.10.3 Inflammation
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diclofenac Active Pharmaceutical Ingredients Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Type
13.6.1 Purity (99%-99.5%)
13.6.2 Purity (above 99.5%)
13.6.3 Purity (below 99 %)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diclofenac Active Pharmaceutical Ingredients Market Size Forecast by Applications
13.10.1 Reating Pain
13.10.2 Fever
13.10.3 Inflammation
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diclofenac Active Pharmaceutical Ingredients Market: Competitive Dashboard
14.2 Global Diclofenac Active Pharmaceutical Ingredients Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Granules India Limited
14.3.2 Huagang Pharm
14.3.3 Hebei Jiheng Pharmaceutical
14.3.4 Zhejiang Kangle Pharmaceutical
14.3.5 Jingye Group
14.3.6 Hunan Zhongnan Pharmaceutical
14.3.7 Elam Pharma Pvt. Ltd. (EPPL)
14.3.8 Watanabe Chemical Co., Ltd
14.3.9 Virchow Laboratories Limited